Cargando…
New anti HCV drugs in the pipeline
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316049/ http://dx.doi.org/10.1186/1742-4690-7-S1-I24 |
_version_ | 1782228334605762560 |
---|---|
author | Bourlière, Marc |
author_facet | Bourlière, Marc |
author_sort | Bourlière, Marc |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3316049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33160492012-03-31 New anti HCV drugs in the pipeline Bourlière, Marc Retrovirology Invited Speaker Presentation BioMed Central 2010-05-11 /pmc/articles/PMC3316049/ http://dx.doi.org/10.1186/1742-4690-7-S1-I24 Text en Copyright ©2010 Bourlière; licensee BioMed Central Ltd. |
spellingShingle | Invited Speaker Presentation Bourlière, Marc New anti HCV drugs in the pipeline |
title | New anti HCV drugs in the pipeline |
title_full | New anti HCV drugs in the pipeline |
title_fullStr | New anti HCV drugs in the pipeline |
title_full_unstemmed | New anti HCV drugs in the pipeline |
title_short | New anti HCV drugs in the pipeline |
title_sort | new anti hcv drugs in the pipeline |
topic | Invited Speaker Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316049/ http://dx.doi.org/10.1186/1742-4690-7-S1-I24 |
work_keys_str_mv | AT bourlieremarc newantihcvdrugsinthepipeline |